CSS LLC’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,100
| Closed | -$1.28M | – | 1056 |
|
|
2020
Q3 | $1.28M | Buy |
+15,100
| New | +$764K | 0.06% | 256 |
|
|
2019
Q1 | – | Sell |
-20,000
| Closed | -$285K | – | 614 |
|
|
2018
Q4 | $285K | Hold |
20,000
| – | – | 0.02% | 343 |
|
|
2018
Q3 | $417K | Hold |
20,000
| – | – | 0.02% | 329 |
|
|
2018
Q2 | $473K | Hold |
20,000
| – | – | 0.02% | 309 |
|
|
2018
Q1 | $292K | Sell |
20,000
-132,100
| -87% | -$2.16M | 0.01% | 364 |
|
|
2017
Q4 | $2.46M | Hold |
152,100
| – | – | 0.12% | 128 |
|
|
2017
Q3 | $2.13M | Buy |
152,100
+40,000
| +36% | +$399K | 0.1% | 149 |
|
|
2017
Q2 | $990K | Hold |
112,100
| – | – | 0.05% | 245 |
|
|
2017
Q1 | $726K | Sell |
112,100
-95,700
| -46% | -$485K | 0.04% | 270 |
|
|
2016
Q4 | $763K | Sell |
207,800
-100
| -0% | -$296 | 0.04% | 278 |
|
|
2016
Q3 | $675K | Sell |
207,900
-50,500
| -20% | -$141K | 0.03% | 317 |
|
|
2016
Q2 | $598K | Buy |
258,400
+162,400
| +169% | +$543K | 0.04% | 319 |
|
|
2016
Q1 | $239K | Buy |
96,000
+10,000
| +12% | +$22.5K | 0.01% | 495 |
|
|
2015
Q4 | $264K | Buy |
86,000
+53,500
| +165% | +$149K | 0.02% | 495 |
|
|
2015
Q3 | $56K | Hold |
32,500
| – | – | ﹤0.01% | 699 |
|
|
2015
Q2 | $132K | Buy |
+32,500
| New | +$133K | 0.01% | 700 |
|
CSS LLC's IMMU Position: Q4 2020 in Review
CSS LLC sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,000 shares — an estimated $255K sold.
CSS LLC first reported a position in IMMU in Q2 2016 and held it in 10 quarters. The position peaked at $431K in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- CSS LLC reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- CSS LLC sold 3,000 Immunomedics Inc shares in Q4 2020, an estimated $255K.
- CSS LLC first reported a position in Immunomedics Inc in Q2 2016 and held it in 10 quarters.
- CSS LLC's Immunomedics Inc position peaked at $431K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on CSS LLC's 13F filing for Q4 2020, filed 16 Feb 2021.